Danaher/DHR

$247.77

-0.89%
-
1D1W1MYTD1YMAX

About Danaher

Danaher Corporation designs, manufactures and markets professional, medical, industrial, and commercial products and services. The Company’s Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables and services that are used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. Its Life Sciences segment offers a range of instruments and consumables that are used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites, and cells. The Life Sciences segment also offers antibodies, reagents, biomarkers, and assays through Abcam plc (Abcam). Its Diagnostics segment offers clinical instruments, reagents, consumables, software that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease.
Ticker
DHR
Sector
Healthcare
Trading on
NYSE
Industry
Scientific & Technical Instr.
CEO
Steven Rales
Employees
79,000
Headquarters
Washington, United States

Danaher Metrics

BasicAdvanced
$184.73B
Market cap
39.27
P/E ratio
$6.37
EPS
0.84
Beta
$1.06
Dividend rate
0.38%
Dividend yield

What the Analysts think about Danaher

Analyst Ratings

Majority rating from 26 analysts.
Buy

Price Targets

Average projection from 20 analysts.
5.22% upside
High $290.00
Low $210.00
$247.77
Current price
$260.70
Average price target

Danaher Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
16.84% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$6.41B
-63.37%
Net income
$1.08B
-70.72%
Profit margin
16.84%
-20.08%

Danaher Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 9.61%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$2.36
$2.05
$2.02
$2.09
-
Expected
$2.25
$2.01
$1.87
$1.91
$1.71
Surprise
4.89%
2.19%
8.28%
9.61%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Danaher stock

Buy or sell Danaher stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing